Double-blind, Randomized Controlled Study in Non-Hodgkin's Lymphoma
- Study Title
- A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects
- Teva Identifier
- NHL-TL011-102
- ClinicalTrials.gov Identifier
- NCT01205737
- Study Status
- Completed
- Trial Condition(s)
- DLBCL
- Interventions
- Biological: TL011 | Biological: Rituximab
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 80 Years
- Trial Duration
- 09/01/2010 - 09/01/2013
- Phase
- Phase 1
